首页> Annals of oncology : official journal of the European Society for Medical Oncology> Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).

Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC).

导出原文传递

翻译打印收藏纠错

第一作者： S J L,Mesnage

第一单位： INSERM U981 Gynaecological Tumours, Gustave Roussy Cancer Center, Villejuif.

作者： S J L,Mesnage ^[1] ; A,Auguste ^[2] ; C,Genestie ^[3] ; A,Dunant ^[4] ; E,Pain ^[1] ; F,Drusch ^[5] ; S,Gouy ^[6] ; P,Morice ^[6] ; E,Bentivegna ^[6] ; C,Lhomme ^[7] ; P,Pautier ^[7] ; J,Michels ^[7] ; A,Le Formal ^[2] ; B,Cheaib ^[7] ; J,Adam ^[3] ; A F,Leary ^[8]

作者单位： INSERM U981 Gynaecological Tumours, Gustave Roussy Cancer Center, Villejuif. ^[1] INSERM U981 Gynaecological Tumours, Gustave Roussy Cancer Center, Villejuif.;Faculty of Sciences, University Paris-Sud, Orsay. ^[2] INSERM U981 Gynaecological Tumours, Gustave Roussy Cancer Center, Villejuif.;Departments of Biopathology, Gustave Roussy, Villejuif, France. ^[3] Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France. ^[4] Translational Research and Histocytopathology Laboratory, Gustave Roussy, 114 rue E Vaillant, 94805, Villejuif, France. ^[5] Gustave Roussy, Université Paris-Saclay, Department of Gynecologic Surgery, F-94805, Villejuif, France. ^[6] Oncology, Gustave Roussy Cancer Center, Villejuif, France. ^[7] INSERM U981 Gynaecological Tumours, Gustave Roussy Cancer Center, Villejuif.;Faculty of Sciences, University Paris-Sud, Orsay.;Oncology, Gustave Roussy Cancer Center, Villejuif, France. ^[8]

关键词 PD-L1 epithelial ovarian cancer neoadjuvant chemotherapy tumour infiltrating lymphocytes